Tag: Cardiac Insight

Cardiac Insight Launches New Telehealth Solution for Cardiology Practices with Heart@Home™ ECG Test Kit

Direct-to-patient Cardea SOLO™ wearable ECG speeds clinical decision-making while removing costly and time-consuming outsourcing of data analysis Bellevue, WA, April 16, 2020 (GLOBE NEWSWIRE) — Cardiac Insight, Inc., a US-based digital healthcare innovator specializing in body-worn sensor technology and automated electrocardiogram (ECG)-analysis software, announces the Heart@Home™ ECG Test Kit to address new telehealth demands placed on cardiology practices […]

Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.) to Expand the Use of Its Wearable Cardiac Sensors in Regulated Pharmaceutical Clinical Trials and Other Healthcare Research Applications

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac biosensors and clinical diagnostic software systems featuring proprietary automated data analysis algorithms, announced today it has partnered with VivoSense®, a leader in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will deliver enhanced research analytics to […]

Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced today that its wearable ECG Sensor, Cardea SOLO, continues to attract high-volume cardiology group practices across the U.S. The company unveiled Baltimore Heart Associates of Maryland (www.baltimoreheart.com) and Regional Cardiac Arrhythmia of […]

USX Denali Expedition Successfully Obtains High-Altitude Cardiac Data Using Cardiac Insight, Inc. Wearable ECG Sensor, Cardea SOLO™

KIRKLAND, Wash.–(BUSINESS WIRE)–You love the outdoors – but your heart might not. If you enjoy skiing, hiking and other sports experienced at high altitudes, you might be well advised to spend your first day at altitude taking it easy. In older men, especially those unaccustomed to intense physical exertion and with coronary artery disease (CAD) […]

Cardiac Insight, Inc. to Showcase Industry-First Cardiac Devices for Atrial Fibrillation and Sudden Cardiac Arrest Risk Detection at Heart Rhythm 2018, Heart Rhythm Society’s 39th Annual Scientific Sessions, May 9-11, Exhibit 1071

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac medical devices and diagnostic software systems with proprietary algorithms, announced today the company will showcase its innovative solutions for the first time at Heart Rhythm Society’s 39th Annual Scientific Sessions. Heart Rhythm 2018 will be held May 9-11, 2018 in the Boston Convention and […]

Cardiac Insight, Inc. to Showcase Wearable Devices and Systems for Atrial Fibrillation and Sudden Cardiac Death Risk Detection at the American College of Cardiology’s 67th Annual Scientific Session, March 10-12, Booth #2417

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company will showcase its one-of-a-kind cardiac devices and software systems, featuring proprietary algorithms, for the first time at a major cardiology exposition at the annual American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo. The […]

Cardiac Insight, Inc. Continues Steady Beat of Progress with New $4.5 Million Investment and Attracts Prestigious Healthcare M&A Executive, Clifford J. Stocks, to Its Board of Directors

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that the company continues to experience a steady beat of market traction and industry endorsement with a recent infusion of $4.5 million into their new C-1 round of funding, currently capped at $10 million, and the addition of […]

Cardiac Insight Announces FDA Clearance of “CARDEA SOLO™” – The First Wearable (ECG) Sensor Giving Physicians Immediate Access to Complete Cardiac Arrhythmia Data and Analysis

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced today, the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO™. The device offers physicians immediate access to improved reporting and analysis of heartbeat-to-heartbeat data. The design and ease of use also encourage better patient compliance for […]